Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Signos vs Thriving Again

Signos
Graded #293

Higher grade

vs+1.8999999999999986
Thriving Again
Graded #341

Lower grade

The verdict

Signos takes it — 61.4/100 to 59.5/100, but only just.

Signos grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Signos (Signos+) is a metabolic-health platform that bundles clinician-prescribed compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor (CGM) and app — pairing the medication with… Thriving Again is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueThriving Again +1
44
45
Dose & formulationSignos +24
64
40
Clinical oversightSignos +8
84
76
Labs & monitoringThriving Again +17
71
88
FulfillmentSignos +9
71
62
Contract termsThriving Again +35
20
55
Signos · left barThriving Again · right bar

The numbers

MetricSignosThriving Again
WeighScore61.4/10059.5/100
GradeCC
Scorecard rank#293#341
Semaglutide$199/mo (6-month plan, compounded)Not disclosed
Tirzepatide$199/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Signos

Graded #293 · C

Strengths

  • Bundles compounded GLP-1 (semaglutide) with an FDA-cleared CGM and app — glucose-guided weight loss, not just medication
  • Starting at $199/mo on a 6-month program, with the CGM included at no extra cost
  • Free rapid shipping; HSA/FSA eligible
  • Real-time glucose insights and app coaching to help sustain results after GLP-1

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Headline price is a 6-month-program rate, not month-to-month
  • Only semaglutide is shown in the program; tirzepatide availability is not confirmed
  • Compounding pharmacy partner and state availability are not published on the landing page
Thriving Again

Graded #341 · C

Strengths

  • Compounded GLP-1 with at-home labs and ongoing provider messaging
  • Advertises nationwide coverage with 500+ licensed providers
  • Pre-filled syringe delivery simplifies dosing
  • Combines weight loss with hormone and peptide optimization

Where it loses points

  • No specific GLP-1 dose or monthly pricing published online
  • Weight loss is one vertical alongside men's hormone and TRT care
  • Compounded products are not FDA-approved or evaluated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard